Ragweed MATAMPL

BIOLOGICAL2 trials

Sponsors

Allergy Therapeutics

Conditions

Type I Hypersensitivity

Phase 2

Investigation of Efficacy and Safety of Ragweed MATAMPL, Pollinex-R and Placebo in Patients With Ragweed Allergy

CompletedNCT00110786

Allergy TherapeuticsType I Hypersensitivity

Start: 2005-05-31End: 2005-12-31Target: 240Updated: 2010-06-17

Follow-up Investigation of Efficacy of Ragweed MATAMPL,and Placebo in Patients With Ragweed-induced Seasonal Allergic Rhinitis

CompletedNCT00325338

Allergy TherapeuticsType I Hypersensitivity

Start: 2006-05-31End: 2006-07-31Target: 100Updated: 2010-06-17